NYSE:GRX
The Gabelli Healthcare & Wellness Trust Stock News
$9.88
-0.0200 (-0.202%)
At Close: May 16, 2024
Rockefeller Capital Management L.P. Boosts Stake in GAMCO Global Gold Ntrl Rsrcs & Incm Trst (NYSEAMERICAN:GGN)
05:58am, Wednesday, 10'th Jun 2020
Rockefeller Capital Management L.P. lifted its position in shares of GAMCO Global Gold Ntrl Rsrcs & Incm Trst (NYSEAMERICAN:GGN) by 188.8% during the 1st quarter, according to the company in its most
2,470 Shares in Liberty Braves Group Series A (NASDAQ:BATRA) Purchased by Acadian Asset Management LLC
05:30am, Wednesday, 10'th Jun 2020
Acadian Asset Management LLC acquired a new position in Liberty Braves Group Series A (NASDAQ:BATRA) during the first quarter, HoldingsChannel.com reports. The institutional investor acquired 2,470 sh
Robert W. Baird Initiates Coverage on Herc (NYSE:HRI)
04:34am, Wednesday, 10'th Jun 2020
Equities research analysts at Robert W. Baird started coverage on shares of Herc (NYSE:HRI) in a research note issued to investors on Monday, Marketbeat Ratings reports. The brokerage set an “outper
Bank of New York Mellon Corp Sells 8,430 Shares of Consolidated Communications Holdings Inc (NASDAQ:CNSL)
04:24am, Wednesday, 10'th Jun 2020
Bank of New York Mellon Corp reduced its holdings in shares of Consolidated Communications Holdings Inc (NASDAQ:CNSL) by 1.0% during the 1st quarter, according to the company in its most recent 13F fi
Akorn, Inc. (NASDAQ:AKRX) Shares Sold by BlackRock Inc.
04:02am, Wednesday, 10'th Jun 2020
BlackRock Inc. cut its position in shares of Akorn, Inc. (NASDAQ:AKRX) by 2.2% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutio
GDL Fund (NYSE:GDL) Share Price Passes Above 200-Day Moving Average of $8.67
03:32am, Wednesday, 10'th Jun 2020
Shares of GDL Fund (NYSE:GDL) passed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $8.67 and traded as high as $8.70. GDL Fund
The GDL Fund Annual Meeting of Shareholders
12:00am, Wednesday, 20'th May 2020
The GDL Fund (NYSE:GDL) (the “Fund”) announced that it will host the 2020 Annual Meeting of Shareholders (the “Annual Meeting”) as a virtual meeting o
The Board of Trustees of The Gabelli Healthcare & WellnessRx Trust (NYSE:GRX) (the "Fund") reaffirmed its quarterly distribution policy and declared a $0.14 per share cash distribution payable on June
The Board of Directors of The Gabelli Convertible and Income Securities Fund Inc. (NYSE:GCV) (the “Fund”) declared a $0.12 per share cash distribution
Global P-hydroxybenzoic Acid Market 2020 Size, Share, Growth, Trends and Forecast 2024, Business Opportunities and Future Investments
08:26am, Wednesday, 13'th May 2020
May 13, 2020 (The Expresswire) --
Global “ P-hydroxybenzoic Acid Market” Report 2020 analyzing the current state of the Market. It provides brief overview of...
May 12, 2020 (The Expresswire) --
“Carton Bottle Market” report 2020 delivers future development strategies, key companies, possibility of competition, major...
Microscope Objectives Market Size Latest Report 2020 Global Technology, Development, Trends and Forecasts to 2026
06:37am, Monday, 11'th May 2020
May 11, 2020 (The Expresswire) --
"Final Report will add the analysis of the impact of COVID-19 on this industry." Global “Microscope Objectives Market”...
Disposable Blood Collection Needle Market Size 2020 Global Industry Trends, Growth, Share and 2026 Forecast Research Report
12:10pm, Friday, 08'th May 2020
May 08, 2020 (The Expresswire) --
“Disposable Blood Collection Needle Market” size analysis report 2020 delivers the latest industry data and future trends,...
Weekly Closed-End Fund Roundup: ASG/USA Lower Distributions (April 17, 2020)
08:09pm, Wednesday, 29'th Apr 2020
14 out of 23 CEF sectors positive on price and 19 out of 23 sectors positive on NAV this week. ASG/USA lower distributions in line with variable distribution po
FDA cautions on use of malaria drugs for COVID-19 outside of hospitals
02:15pm, Friday, 24'th Apr 2020
In a statement, the FDA is cautioning against the use of malaria meds chloroquine and hydroxychloroquine outside of the hospital setting for the treatment of COVID-19 due to the risk of adverse heart